Current acceptance of the hpv vaccine

Nurse Practitioner

Volumn 33, Issue 4, 2008, Pages 18-22

  Miller, Megan M ^a   Wilson, Julie M ^b   Waldrop, Julee ^c  

^a Growing Child   (United States)

^b Cary Skin Center   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; WART VIRUS VACCINE;

ADOLESCENT; ADULT; CHILD; EDUCATION; FEMALE; HEALTH CARE PLANNING; HUMAN; IMMUNOLOGY; NURSE PRACTITIONER; PARENT; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; REVIEW; SAFETY; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; NURSE PRACTITIONERS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; SAFETY; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 45549094632     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000314751.72798.cc     Document Type: Article

References (29)

1. Trottier H, Franco E. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;Mar 30;24(Suppl 1):S1-15.
2. Friedman A, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC Focus Group Research and implications for practice. Health Education and Behavior 2006;20:1-15.
3. Stanley M. HPV vaccines. Best Pract Res Clin Obstet Gynecol. 2006;20(2):279-293.
4. Kahn JA. Vaccination as a prevention strategy for human papillomavirus-related diseases. J Adolesc Health. 2005;37(6S):S10-S16.
5. Centers for Disease Control and Prevention: Cervical cancer statistics.
6. Merck. Merck's investigational vaccine Gardasil prevented 100 percent of cervical pre-cancers and no invasive cervical cancers associated with HPV types 16 and 18 in new clinical study.
7. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicenter phase II efficacy trial. Lancet Oncol. 2005;6:271-278.
8. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up froma randomizsed control trial. Lancet 2006;367:1247-1255.
9. Fraser C, Tomassini JE, Xi L, et al. Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine. 2007;25:4324-4333.
10. FDA. Product approval information - licensing action. 2006.
11. Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: The attitudes of nurse practitioners. Sex Trans Dis. 2004;31(7):428-432.
12. Raley JC, Followwill KA, Zimet GD, et al. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol. 2004;12(3-4):127-133.
13. Riedesel JM, Rosenthal SL, Zimet GD, et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol. 2005;18(6):391-398.
14. Daley MF, Liddon N, Crane LA, et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 2006;118(6):2280-2289.
15. Kahn JA, Zimet GD, Bernstein DL, et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health. 2005;37(6):502-510.
16. Kahn JA, Rosenthal SL, Hamann T, et al. Attitudes about human papillomavirus vaccine in young women. Intl J STD AIDS. 2003;14(5):300-306.
17. Boehner C, Howe S, Bernstein D, et al.: Viral sexually transmitted disease vaccine acceptability among college students. Sex Trans Dis. 2003;30(10):774-778.
18. Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188-194
19. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58(7):1402-1413.
20. Dempsey A, Zimet G, Davis R, et al. Factors that are associated with parental acceptance of human papillomavirus vaccine: A randomized intervention study of written information about HPV. Pediatrics. 2006;117(5):1486-1493.
21. Olshen E, Woods ER, Austin SB, et al. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health. 2005;37(3):248-251.
22. Waller J, Marlow LA, Wardle J. Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: A qualitative study. Cancer Epidemiol Biomarkers Prev. 2006;15:1257-1261.
23. Slomovitz B, Sun C, Frumovitz M, et al. Are women ready for the HPV vaccine? Gynecol Oncol. 2006;103:151-154.
24. Zimet GD, Mays RA, Sturm L, et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med. 2005;159(2):132-137.
25. Robinson D, Kish C. Core concepts in advanced practice nursing. St. Louis, MO: Mosby, 2001.
26. Zimet GD. Improving adolescent health: Focus on HPV vaccine acceptance. J Adolesc Health. 2005;37(Suppl 1):S17-S23.
27. Rosenthal S, Kottenhahn R, Biro F et al. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health. 1995;17:248-254.
28. Taylor JA, Newman RD. Parental attitudes toward varicella vaccination. The Puget Sound Pediatric Research Network. Arch Pediatr Adolesc Med. 2000;154(3):302-306.
29. CDC. Youth risk behavior surveillance - U.S. 2005. MMWR. 2006;55(ss-5):1-108.